Search
Search Results
-
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer
Abstract BackgroundProgrammed death-ligand 1 (PD-L1) expression is a predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC)....
-
Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis
ObjectiveFluorine-18 fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) and PET/CT have been suggested for confirming or excluding...
-
Importance of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in detection of post-thyroidectomy recurrence in differentiated thyroid cancer with negative radio-isotope iodine scan, yet, elevated serum thyroglobulin level
BackgroundThyroid cancer considered the 6th common cancer in female and represents approximately 1% of all cancers. Thyroid cancer is generally...
-
A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images
IntroductionAmyloid-β (Aβ) plaques is a significant hallmark of Alzheimer's disease (AD), detectable via amyloid-PET imaging. The...
-
From FDG and beyond: the evolving potential of nuclear medicine
The radiopharmaceutical 2-[fluorine-18]fluoro-2-deoxy- d -glucose (FDG) has been dominantly used in positron emission tomography (PET) scans for over...
-
Semiquantitative 18F-FDG PET/CT in monitoring glucocorticoid response of immunoglobulin G4-related effusive constrictive pericarditis: a case report
BackgroundImmunoglobulin G4 (IgG4)-related effusive constrictive pericarditis (ECP) is a rare manifestation of IgG4-related disease (IgG4-RD). It can...
-
Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors
BackgroundPreoperative fluorine-18-fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) of thymic epithelial tumors (TETs) is well known...
-
Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
BackgroundFluorine 18 ( 18 F) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has limitations in staging...
-
A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy
PurposeA series of radiotracers targeting fibroblast activation protein (FAP) with great pharmacokinetics have been developed for cancer diagnosis...
-
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker
Despite advances in chemotherapy, the drugs used in cancer treatment remain rather harmful to the cardiovascular system, causing structural and...
-
18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT
BackgroundThe aim of this study was to evaluate the efficacy of fluorine 18 ( 18 F) labeled fibroblast activation protein inhibitor (FAPI) in...
-
Diagnostic value of FDG PET-CT in differentiating lung adenocarcinoma from squamous cell carcinoma
BackgroundLung cancer is the leading cause of cancer-related deaths worldwide. The combination of fluorine-18 fluorodeoxyglucose positron emission...
-
[18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study
BackgroundThis study investigates the value of fluorine 18 ([ 18 F])-labeled fibroblast activation protein inhibitor (FAPI) for lymph node (LN)...
-
[18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects
PurposePET/MRI has become an important medical imaging approach in clinical practice. In this study, we retrospectively investigated the...
-
A diagnostic model based on 18F-FDG PET/CT parameters in improving the differential diagnosis of invasive thymic epithelial tumors and anterior mediastinal lymphomas
BackgroundAccurately distinguishing between invasive thymic epithelial tumors (TETs) and anterior mediastinal lymphoma before surgery is crucial for...
-
Physiological 2-deoxy-2-[fluorine-18] fluoro-D-glucose accumulation in the thenar eminence in adults: a single-center retrospective study
ObjectiveThis study evaluated the frequency, and effect of physiological 2-deoxy-2-[fluorine-18] fluoro- D -glucose (FDG) tracer injection and its...
-
FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma
PurposeWe investigated the prognostic value of maximum tumor dissemination (Dmax), the distance between malignant lesions that were farthest apart,...
-
Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT
BackgroundWe assessed the value of positron emission tomography/computed tomography (PET/CT) with [ 13 N]N-ammonia ([ 13 N]N-NH3) and [ 11 C]C-methionine...
-
Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patients
ObjectiveTo explore the significance of Fluorine-18 labeled fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in...
-
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis
ObjectivesThis study aims to evaluate the utility of F-18 FDG PET/CT in the non-invasive diagnosis of autoimmune pancreatitis (AIP) and...
